Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination - PubMed (original) (raw)

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

Takayasu Suganuma et al. Clin Cancer Res. 2005.

Abstract

Purpose: Angiotensin II is a bioactive peptide of the renin-angiotensin system, acting not only as a vasoconstrictor but also as a growth promoter via angiotensin II type 1 receptors (AT1R). The present study examined AT1R expression in human ovarian carcinoma and attempted to determine whether AT1R blocker could suppress the tumor progression.

Experimental design: Expression of AT1R, vascular endothelial growth factor (VEGF), and CD34 was immunohistochemically analyzed in ovarian tumor tissues (n=99). Effects of AT1R blocker on invasive potential and VEGF secretion in ovarian cancer cells were examined in vitro. Effects of AT1R blocker in vivo were evaluated in a mouse model of peritoneal carcinomatosis.

Results: AT1R was expressed in 57 of 67 (85%) invasive ovarian adenocarcinomas and 12 of 18 (66%) borderline malignant tumors but in only 2 of 14 (14%) benign cystadenomas. In invasive carcinomas, VEGF expression intensity and intratumor microvessel density were significantly higher in cases that were strongly positive for AT1R (n = 37) compared with those in cases weakly positive (n = 20) or negative (n = 10) for AT1R. Angiotensin II significantly enhanced the invasive potential and VEGF secretion in AT1R-positive SKOV-3 ovarian cancer cells, both of which were completely inhibited by the AT1R blocker candesartan. Administration of candesartan into SKOV-3-transplanted athymic mice resulted in the reduction of peritoneal dissemination, decreased ascitic VEGF concentration, and suppression of tumor angiogenesis.

Conclusions: AT1R is functionally expressed in ovarian carcinoma and involved in tumor progression and angiogenesis. AT1R blockade therapy may become a novel and promising strategy for ovarian cancer treatment.

PubMed Disclaimer

Cited by

Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease.
Wagner N, Wagner KD. Wagner N, et al. Int J Mol Sci. 2023 Jan 25;24(3):2345. doi: 10.3390/ijms24032345. Int J Mol Sci. 2023. PMID: 36768666 Free PMC article. Review.
CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
McAuley JR, Freeman TJ, Ekambaram P, Lucas PC, McAllister-Lucas LM. McAuley JR, et al. Front Immunol. 2018 Aug 15;9:1887. doi: 10.3389/fimmu.2018.01887. eCollection 2018. Front Immunol. 2018. PMID: 30158935 Free PMC article. Review.
Synthesis and Evaluation of [18F]FEtLos and [18F]AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors.
Sahylí Ortega Pijeira M, Sérgio Gonçalves Nunes P, Nascimento Dos Santos S, Zhang Z, Pérez Nario A, Araujo Perini E, Miguel Turato W, Rodríguez Riera Z, Chammas R, H Elsinga P, Lin KS, Carvalho I, Soares Bernardes E. Sahylí Ortega Pijeira M, et al. Molecules. 2020 Apr 18;25(8):1872. doi: 10.3390/molecules25081872. Molecules. 2020. PMID: 32325695 Free PMC article.
Role of Renin-Angiotensin-System in Human Breast Cancer Cells: Is There a Difference in Regulation of Angiogenesis between Hormone-Receptor Positive and Negative Breast Cancer Cells?
Herr D, Sauer C, Holzheu I, Sauter R, Janni W, Wöckel A, Wulff C. Herr D, et al. Geburtshilfe Frauenheilkd. 2019 Jun;79(6):626-634. doi: 10.1055/a-0887-7313. Epub 2019 Jun 14. Geburtshilfe Frauenheilkd. 2019. PMID: 31217631 Free PMC article.
Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
Zhang Q, Yu S, Lam MMT, Poon TCW, Sun L, Jiao Y, Wong AST, Lee LTO. Zhang Q, et al. J Exp Clin Cancer Res. 2019 Mar 7;38(1):116. doi: 10.1186/s13046-019-1127-x. J Exp Clin Cancer Res. 2019. PMID: 30845964 Free PMC article.

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination - PubMed (original) (raw)